115 related articles for article (PubMed ID: 38260493)
1. STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity.
Wang J; Li S; Wang M; Wang X; Chen S; Sun Z; Ren X; Huang G; Sumer BD; Yan N; Fu YX; Gao J
bioRxiv; 2024 Jan; ():. PubMed ID: 38260493
[TBL] [Abstract][Full Text] [Related]
2. STING licensing of type I dendritic cells potentiates antitumor immunity.
Wang J; Li S; Wang M; Wang X; Chen S; Sun Z; Ren X; Huang G; Sumer BD; Yan N; Fu YX; Gao J
Sci Immunol; 2024 Feb; 9(92):eadj3945. PubMed ID: 38363830
[TBL] [Abstract][Full Text] [Related]
3. Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.
Conde E; Vercher E; Soria-Castellano M; Suarez-Olmos J; Mancheño U; Elizalde E; Rodriguez ML; Glez-Vaz J; Casares N; Rodríguez-García E; Hommel M; González-Aseguinolaza G; Uranga-Murillo I; Pardo J; Alkorta G; Melero I; Lasarte J; Hervas-Stubbs S
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34810235
[TBL] [Abstract][Full Text] [Related]
4. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
5. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
6. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
[TBL] [Abstract][Full Text] [Related]
7. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
[TBL] [Abstract][Full Text] [Related]
9. Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Jneid B; Bochnakian A; Hoffmann C; Delisle F; Djacoto E; Sirven P; Denizeau J; Sedlik C; Gerber-Ferder Y; Fiore F; Akyol R; Brousse C; Kramer R; Walters I; Carlioz S; Salmon H; Malissen B; Dalod M; Piaggio E; Manel N
Sci Immunol; 2023 Jan; 8(79):eabn6612. PubMed ID: 36638189
[TBL] [Abstract][Full Text] [Related]
10. Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy.
Nguyen DC; Song K; Jokonya S; Yazdani O; Sellers DL; Wang Y; Zakaria A; Pun SH; Stayton PS
ACS Cent Sci; 2024 Mar; 10(3):666-675. PubMed ID: 38559305
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake.
de Mingo Pulido Á; Hänggi K; Celias DP; Gardner A; Li J; Batista-Bittencourt B; Mohamed E; Trillo-Tinoco J; Osunmakinde O; Peña R; Onimus A; Kaisho T; Kaufmann J; McEachern K; Soliman H; Luca VC; Rodriguez PC; Yu X; Ruffell B
Immunity; 2021 Jun; 54(6):1154-1167.e7. PubMed ID: 33979578
[TBL] [Abstract][Full Text] [Related]
12. Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.
Deb P; Dai J; Singh S; Kalyoussef E; Fitzgerald-Bocarsly P
J Immunol; 2020 Jul; 205(1):223-236. PubMed ID: 32471881
[TBL] [Abstract][Full Text] [Related]
13. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T
Benoit-Lizon I; Jacquin E; Rivera Vargas T; Richard C; Roussey A; Dal Zuffo L; Martin T; Melis A; Vinokurova D; Shahoei SH; Baeza Garcia A; Pignol C; Giorgiutti S; Carapito R; Boidot R; Végran F; Flavell RA; Ryffel B; Nelson ER; Soulas-Sprauel P; Lawrence T; Apetoh L
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091453
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Podofilox as a Potent cGAMP-STING Signaling Enhancer with Antitumor Activity.
Han J; Hu S; Hu Y; Xu Y; Hou Y; Yang Y; Su H; Zhang Z; Liu P; Sun X; Zhang C
Cancer Immunol Res; 2023 May; 11(5):583-599. PubMed ID: 36921097
[TBL] [Abstract][Full Text] [Related]
15. Cyclic GMP-AMP promotes the acute phase response and protects against Escherichia coli infection in mice.
Yu Y; Guo H; Jiang W; Zhang C; Xing C; Chen D; Xu C; Su L
Biochem Pharmacol; 2021 Jun; 188():114541. PubMed ID: 33812857
[TBL] [Abstract][Full Text] [Related]
16. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
17. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel JC; Crozat K; Dalod M; Mattiuz R
Front Immunol; 2019; 10():9. PubMed ID: 30809220
[TBL] [Abstract][Full Text] [Related]
18. Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity.
Lemos H; Ou R; McCardle C; Lin Y; Calver J; Minett J; Chadli A; Huang L; Mellor AL
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32847988
[TBL] [Abstract][Full Text] [Related]
19. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
Liang L; Shen Y; Hu Y; Liu H; Cao J
PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
[TBL] [Abstract][Full Text] [Related]
20. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation.
Alshebremi M; Tomchuck SL; Myers JT; Kingsley DT; Eid S; Abiff M; Bonner M; Saab ST; Choi SH; Huang AY
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
